From genotype to phenotype in human atherosclerosis - Recent findings

Current Opinion in Lipidology

Volumn 24, Issue 5, 2013, Pages 410-418

  Holdt, Lesca M ^a   Teupser, Daniel ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ACTIN REGULATOR 1; BECLIN 1; BINDING PROTEIN; CADHERIN; COMPLEMENTARY RNA; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; EPIDERMAL GROWTH FACTOR; LIPID; LONG UNTRANSLATED RNA; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MESSENGER RNA; MYOSIN; PHOSPHOPROTEIN PHOSPHATASE 1; PROLINE; SERINE; SORTILIN; STAT1 PROTEIN; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR RISK; CELL MIGRATION; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN METABOLISM; MAJOR DEPRESSION; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SEGREGATION ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

ATHEROSCLEROSIS; CHROMOSOMES, HUMAN; EPIGENESIS, GENETIC; GENETIC LOCI; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS;

EID: 84883780487     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0b013e3283654e7c     Document Type: Review

References (90)

1. Helgadottir A, Thorleifsson G, Manolescu A, et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007; 316:1491-1493
2. McPherson R, Pertsemlidis A, Kavaslar N, et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007; 316:1488-1491
3. Samani NJ, Erdmann J, Hall AS, et al. Genome-wide association analysis of coronary artery disease. N Engl J Med 2007; 357:443-453
4. WTCCC. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-678
5. 2-LPA gene cluster as a risk locus for coronary artery disease. Nat Genet 2009; 41:283-285
6. Erdmann J, Grosshennig A, Braund PS, et al. New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet 2009; 41:280-282
7. Erdmann J, Willenborg C, Nahrstaedt J, et al. Genome-wide association study identifies a new locus for coronary artery disease on chromosome 10p11.23
8. Reilly MP, Li M, He J, et al. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: Two genome-wide association studies. Lancet 2011; 377:383-392
9. Coronary Artery Disease (C4D) Genetics Consortium. A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat Genet 2011; 43:339-344
10. Schunkert H, Konig IR, Kathiresan S, et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 2011; 43:333-338
11. Wild PS, Zeller T, Schillert A, et al. A genome-wide association study identifies LIPA as a susceptibility gene for coronary artery disease. Circ Cardiovasc Genet 2011; 4:403-412
12. Slavin TP, Feng T, Schnell A, et al. Two-marker association tests yield new disease associations for coronary artery disease and hypertension. Hum Genet 2011; 130:725-733
13. Takeuchi F, Yokota M, Yamamoto K, et al. Genome-wide association study of coronary artery disease in the Japanese. Eur J Hum Genet 2012; 20:333-340
14. Davies RW, Wells GA, Stewart AF, et al. A genome-wide association study for coronary artery disease identifies a novel susceptibility locus in the major histocompatibility complex. Circ Cardiovasc Genet 2012; 5:217-225
15. Hager J, Kamatani Y, Cazier JB, et al. Genome-wide association study in a Lebanese cohort confirms PHACTR1 as a major determinant of coronary artery stenosis. PLoS One 2012; 7:e38663
16. Lu X, Wang L, Chen S, et al. Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease. Nat Genet 2012; 44:890-894
17. Lee JY, Lee BS, Shin DJ, et al. A genome-wide association study of a coronary artery disease risk variant. J Hum Genet 2013; 58:120-126
18. CARDIoGRAMplusC4D Consortium. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet 2013; 45:25-33
19. Kathiresan S, Voight BF, Purcell S, et al. Genome-wide association of earlyonset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet 2009; 41:334-341
20. Aoki A, Ozaki K, Sato H, et al. SNPs on chromosome 5p15.3 associated with myocardial infarction in Japanese population. J Hum Genet 2011; 56:47-51
21. Hindorff LA, Sethupathy P, Junkins HA, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 2009; 106:9362-9367
22. Lanktree MB, Dichgans M, Hegele RA. Advances in genomic analysis of stroke: What have we learned and where are we headed? Stroke 2010; 41:825-832
23. Murabito JM, White CC, Kavousi M, et al. Association between chromosome 9p21 variants and the ankle-brachial index identified by a meta-Analysis of 21 genome-wide association studies. Circ Cardiovasc Genet 2012; 5:100-112
24. Kjolby M, Andersen OM, Breiderhoff T, et al. Sort1, encoded by the cardiovascular risk locus 1p13.3, is a regulator of hepatic lipoprotein export. Cell Metab 2010; 12:213-223
25. Linsel-Nitschke P, Heeren J, Aherrahrou Z, et al. Genetic variation at chromosome 1p13.3 affects sortilin mRNA expression, cellular LDL-uptake and serum LDL levels which translates to the risk of coronary artery disease. Atherosclerosis 2010; 208:183-189
26. Musunuru K, Strong A, Frank-Kamenetsky M, et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature 2010; 466:714-719
27. Strong A, Ding Q, Edmondson AC, et al. Hepatic sortilin regulates both apolipoprotein B secretion and LDL catabolism. J Clin Invest 2012; 122:2807-2816
28. Folkersen L, van't Hooft F, Chernogubova E, et al. Association of genetic risk variants with expression of proximal genes identifies novel susceptibility genes for cardiovascular disease. Circ Cardiovasc Genet 2010; 3:365-373
29. Zeller T, Wild P, Szymczak S, et al. Genetics and beyond-The transcriptome of human monocytes and disease susceptibility. PLoS One 2010; 5:e10693
30. Holdt LM, Teupser D. Recent studies of the human chromosome 9p21 locus, which is associated with atherosclerosis in human populations. Arterioscler Thromb Vasc Biol 2012; 32:196-206
31. Roberts R, Stewart AF. 9p21 and the genetic revolution for coronary artery disease. Clin Chem 2012; 58:104-112
32. Gieger C, Radhakrishnan A, Cvejic A, et al. New gene functions in megakaryopoiesis and platelet formation. Nature 2011; 480:201-208
33. Ramdas WD, van Koolwijk LM, Ikram MK, et al. A genome-wide association study of optic disc parameters. PLoS Genet 2010; 6:e1000978
34. Sanson M, Hosking FJ, Shete S, et al. Chromosome 7p11.2 (EGFR) variation influences glioma risk. Hum Mol Genet 2011; 20:2897-2904
35. Wiggs JL, Yaspan BL, Hauser MA, et al. Common variants at 9p21 and 8q22 are associated with increased susceptibility to optic nerve degeneration in glaucoma. PLoS Genet 2012; 8:e1002654
36. Bei JX, Li Y, Jia WH, et al. A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat Genet 2010; 42:599-603
37. Turnbull C, Ahmed S, Morrison J, et al. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet 2010; 42:504-507
38. Yasuno K, Bilguvar K, Bijlenga P, et al. Genome-wide association study of intracranial aneurysm identifies three new risk loci. Nat Genet 2010; 42:420-425
39. Uno S, Zembutsu H, Hirasawa A, et al. A genome-wide association study identifies genetic variants in the CDKN2BAS locus associated with endometriosis in Japanese. Nat Genet 2010; 42:707-710
40. O'Donnell CJ, Kavousi M, Smith AV, et al. Genome-wide association study for coronary artery calcification with follow-up in myocardial infarction. Circulation 2011; 124:2855-2864
41. Zeggini E, Scott LJ, Saxena R, et al. Meta-Analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 2008; 40:638-645
42. Freilinger T, Anttila V, de Vries B, et al. Genome-wide association analysis identifies susceptibility loci for migraine without aura. Nat Genet 2012; 44:777-782
43. Kiel DP, Demissie S, Dupuis J, et al. Genome-wide association with bone mass and geometry in the Framingham Heart Study. BMC Med Genet 2007; 8 (Suppl 1):S1
44. Zhang D, Pang Z, Li S, et al. Genome-wide linkage and association scans for pulse pressure in Chinese twins. Hypertens Res 2012; 35:1051-1057
45. Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010; 466:707-713
46. Kottgen A, Pattaro C, Boger CA, et al. New loci associated with kidney function and chronic kidney disease. Nat Genet 2010; 42:376-384
47. Shi J, Potash JB, Knowles JA, et al. Genome-wide association study of recurrent early-onset major depressive disorder. Mol Psychiatry 2011; 16:193-201
48. Kim WY, Sharpless NE. The regulation of INK4/ARF in cancer and aging. Cell 2006; 127:265-275
49. Holdt LM, Sass K, Gabel G, et al. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque. Atherosclerosis 2011; 214:264-270
50. Kim JB, Deluna A, Mungrue IN, et al. Effect of 9p21.3 coronary artery disease locus neighboring genes on atherosclerosis in mice. Circulation 2012; 126:1896-1906
51. Leeper NJ, Raiesdana A, Kojima Y, et al. Loss of CDKN2B promotes p53-dependent smooth muscle cell apoptosis and aneurysm formation. Arterioscler Thromb Vasc Biol 2013; 33:e1-e10
52. Fuster JJ, Molina-Sanchez P, Jovani D, et al. Increased gene dosage of the Ink4/Arf locus does not attenuate atherosclerosis development in hypercholesterolaemic mice. Atherosclerosis 2012; 221:98-105
53. Kuo CL, Murphy AJ, Sayers S, et al. Cdkn2a is an atherosclerosis modifier locus that regulates monocyte/macrophage proliferation. Arterioscler Thromb Vasc Biol 2011; 31:2483-2492
54. Wouters K, Cudejko C, Gijbels MJ, et al. Bone marrow p16INK4a-deficiency does not modulate obesity, glucose homeostasis or atherosclerosis development. PLoS One 2012; 7:e32440
55. Burd CE, Jeck WR, Liu Y, et al. Expression of linear and novel circular forms of an INK4/ARF-Associated noncoding RNA correlates with atherosclerosis risk. PLoS Genet 2010; 6:e1001233
56. Cunnington MS, Santibanez Koref M, Mayosi BM, et al. Chromosome 9p21 SNPs associated with multiple disease phenotypes correlate with ANRIL expression. PLoS Genet 2010; 6:e1000899
57. Folkersen L, Kyriakou T, Goel A, et al. Relationship between CAD risk genotype in the chromosome 9p21 locus and gene expression. Identification of eight new ANRIL splice variants. PLoS One 2009; 4:e7677
58. Holdt LM, Beutner F, Scholz M, et al. ANRIL expression is associated with atherosclerosis risk at chromosome 9p21. Arterioscler Thromb Vasc Biol 2010; 30:620-627
59. Holdt LM, Hoffmann S, Sass K, et al. Alu elements in ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through transregulation of gene networks. PLoS Genet 2013; 9:e1003588
60. Jarinova O, Stewart AF, Roberts R, et al. Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus. Arterioscler Thromb Vasc Biol 2009; 29:1671-1677
61. Johnson AD, Hwang SJ, Voorman A, et al. Resequencing and clinical associations of the 9p21.3 region: A comprehensive investigation in the Framingham heart study. Circulation 2013; 127:799-810
62. Liu Y, Sanoff HK, Cho H, et al. INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis. PLoS One 2009; 4:e5027
63. Harismendy O, Notani D, Song X, et al. 9p21 DNA variants associated with coronary artery disease impair interferon-gamma signalling response. Nature 2011; 470:264-268
64. Congrains A, Kamide K, Katsuya T, et al. CVD-Associated noncoding RNA, ANRIL, modulates expression of atherogenic pathways in VSMC. Biochem Biophys Res Commun 2012; 419:612-616
65. Congrains A, Kamide K, Oguro R, et al. Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B. Atherosclerosis 2012; 220:449-455
66. Kotake Y, Nakagawa T, Kitagawa K, et al. Long noncoding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene 2011; 30:1956-1962
67. Yap KL, Li S, Munoz-Cabello AM, et al. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell 2010; 38:662-674
68. Hung T, Chang HY. Long noncoding RNA in genome regulation: Prospects and mechanisms. RNA Biol 2010; 7:582-585
69. Lee JT. Epigenetic regulation by long noncoding RNAs. Science 2012; 338:1435-1439
70. Wapinski O, Chang HY. Long noncoding RNAs and human disease (vol 21, pg 354, 2011). Trends in Cell Biology 2011; 21:561-1561
71. Gonzalez I, Busturia A. High levels of dRYBP induce apoptosis in Drosophila imaginal cells through the activation of reaper and the requirement of trithorax, dredd and dFADD. Cell Res 2009; 19:747-757
72. Gregoire S, Karra R, Passer D, et al. Essential and unexpected role of YY1 to promote mesodermal cardiac differentiation. Circ Res 2013; 112:900-910
73. Sato K, Nakagawa H, Tajima A, et al. ANRIL is implicated in the regulation of nucleus and potential transcriptional target of E2F1. Oncol Rep 2010; 24:701-707
74. Deininger PL, Jolly DJ, Rubin CM, et al. Base sequence studies of 300 nucleotide renatured repeated human DNA clones. J Mol Biol 1981; 151:17-33
75. Weibrecht I, Gavrilovic M, Lindbom L, et al. Visualising individual sequencespecific protein-DNA interactions in situ. N Biotechnol 2012; 29:589-598
76. Jeck WR, Sorrentino JA, Wang K, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA 2013; 19:141-157
77. Nagase T, Kikuno R, Hattori A, et al. Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res 2000; 7:347-355
78. Allen PB, Greenfield AT, Svenningsson P, et al. Phactrs 1-4: A family of protein phosphatase 1 and actin regulatory proteins. Proc Natl Acad Sci U S A 2004; 101:7187-7192
79. Peti W, Nairn AC, Page R. Structural basis for protein phosphatase 1 regulation and specificity. FEBS J 2013; 280:596-611
80. Fils-Aime N, Dai M, Guo J, et al. MicroRNA-584 and the protein phosphatase and actin regulator 1 (PHACTR1), a new signaling route through which transforming growth factor-beta mediates the migration and actin dynamics of breast cancer cells. J Biol Chem 2013; 288:11807-11823
81. Wiezlak M, Diring J, Abella J, et al. G-Actin regulates the shuttling and PP1 binding of the RPEL protein Phactr1 to control actomyosin assembly. J Cell Sci 2012; 125:5860-5872
82. Allain B, Jarray R, Borriello L, et al. Neuropilin-1 regulates a new VEGFinduced gene, Phactr-1, which controls tubulogenesis and modulates lamellipodial dynamics in human endothelial cells. Cell Signal 2012; 24:214-223
83. Jarray R, Allain B, Borriello L, et al. Depletion of the novel protein PHACTR-1 from human endothelial cells abolishes tube formation and induces cell death receptor apoptosis. Biochimie 2011; 93:1668-1675
84. Kathiresan S, Melander O, Guiducci C, et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 2008; 40:189-197
85. Sandhu MS, Waterworth DM, Debenham SL, et al. LDL-cholesterol concentrations: A genome-wide association study. Lancet 2008; 371:483-491
86. Willer CJ, Sanna S, Jackson AU, et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 2008; 40:161-169
87. Schadt EE, Molony C, Chudin E, et al. Mapping the genetic architecture of gene expression in human liver. PLoS Biol 2008; 6:e107
88. Willnow TE, Kjolby M, Nykjaer A. Sortilins: New players in lipoprotein metabolism. Curr Opin Lipidol 2011; 22:79-85
89. Willnow TE, Petersen CM, Nykjaer A. VPS10P-domain receptors-regulators of neuronal viability and function. Nat Rev Neurosci 2008; 9:899-909
90. Tveten K, Strom TB, Cameron J, et al. Mutations in the SORT1 gene are unlikely to cause autosomal dominant hypercholesterolemia. Atherosclerosis 2012; 225:370-375